Trial Profile
Impact of antirheumatic treatment on the immunogenicity of influenza A virus vaccine H1N1 (Pandemrix) in patients with arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Influenza A virus H1N1 vaccines (Primary) ; Abatacept; Analgesics; Antirheumatics; Methotrexate; Nonsteroidal anti-inflammatories; Rituximab; Tocilizumab; Tumour necrosis factor inhibitors
- Indications Influenza A virus infections
- Focus Therapeutic Use
- 09 Dec 2015 New trial record